Aashni Shah

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +6

78 The HCV NS3 protease inhibitor SCH 503034 in combination with PEG-IFNα-2b in the treatment of HCV-1 PEG-IFNα-2b non-responders: Antiviral activity and HCV variant analysis

S Zeuzem, C. Sarrazin, Frank Wagner et al. · Journal of Hepatology · 2006 · 19 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Do we always need to treat patients with spinal muscular atrophy? A personal view and experience

Caterina Agosto, Eleonora Salamon, Antuan Divisic et al. · Orphanet Journal of Rare Diseases · 2021 · 19 citations · Full text

Medicine, Neurology, Pediatrics +13

Hospital Frailty Risk Score Is Independently Associated with Mortality and Encephalopathy in Hospitalized Patients with Hepatocellular Carcinoma

Daryl Ramai, Khoi Paul Dang-Ho, Anjali Kewalramani et al. · Biomedicines · 2021 · 19 citations · Full text

Medicine, Geriatric Medicine, Oncology +15